Peer-influenced content. Sources you trust. No registration required. This is HCN.

Articles related to NON-SMALL CELL LUNG CANCER (NSCLC)

JAMA Network

Rates of Guideline-Concordant Surgery and Adjuvant Chemotherapy Among Patients with Early-Stage Lung Cancer in the US ALCHEMIST Study (Alliance A151216)

Oncology, Medical March 22nd 2022

NSCLC: FDA Breakthrough Therapy Designation for Targeted EGFR Inhibitor

Oncology, Medical January 19th 2022

Sintilimab Plus Chemo Prolongs Survival in Advanced Non-Small Cell Lung Cancer

Internal Medicine December 21st 2021

Cancer Therapy Advisor

Non-Small Cell Lung Cancer Treatment Regimens

Internal Medicine August 17th 2021

JAMA Network

Association Between First-Line Immune Checkpoint Inhibition and Survival for Medicare-Insured Patients With Advanced Non–Small Cell Lung Cancer

Geriatrics June 2nd 2021

Durvalumab Reduces Mortality Risk vs Chemo in NSCLC With PD-L1 Expression

Cardiology April 14th 2021